Derivatives of bis-(p-chlorophenoxy) acetic acid



United States Patent ice ,fgifflil 3 454 581 of the halide reagent can be employed for this purpose. CHI It is generally preferred to carry out the reaction in the DERIVATIVES A g A presence of a catalytic amount of dimethylformamide. Rudolf G. Griot Florham Park NJ. assignor to Sandoz The reaction 0f the thus-obtained acid halide With the I Hanover, 5 alcohol or alcoholate is conveniently effected in a suitable N0 Drawing. Filed Feb. 21, 1967, Ser. No. 617,455 inert organic solvent, e.g., benzene, toluene, chloroform Int. Cl. C07d 29/02; C07c 69/76; A61k 27/00 and diethyl ether, and at room temperature (20 C.) or 260294-3 4 Clalms below. Preferably the reaction is carried out at a temperature of from about 10 to about 5 C. Where the free 10 alcohol is employed it is desirable to provide a means for ABSTRACT OF THE DISCLOSURE taking up the liberated hydrogen halide. This can be ac- The compounds are of the' class of esters of bis-(pcomplished by employing an excess of the alcohol or by chlorophenoxy)acetic acid, e.g., bis-(p-chlorophenoxy carrying out the reaction in the presence of an alkali metal acetic acid, ester with l-hydroxypiperidine, which are usecarbonate, e.g., potassium carbonate, or suitable inert ful as hypocholesteremic/hypolipemic agents, base, e.g., pyridine. Where an alcoholate is used, the

alkali metal salts, particularly the sodium and potassium salts, are preferred. The desired product thus obtained is This invention relates to derivaties of acetic acid. In readily recovered in conventional manner. particular, the invention pertains to esters of bis-(p-chloro- The preparation of the compound of Formula Ib, via phenoxy)acetic acid which may be represented by the reaction of bis-(p-chlorophenoxy)acetic acid with a halofollowing structural formula: acetonitrile, is readily eifected in a suitable inert organic solvent, e.g., dioxane, tetrahydrofuran and ethyl acetate, CIQO at elevated temperatures up to the reflux temperature of \CHCOOR the system and in the presence of a tertiary amine, e.g., triethylamine, triisobutylamine and pyridine, to take up l-Q I the liberated hydrogen halide. Preferably, the reaction is carried out in ethylacetate at reflux temperature and in Wherem the presence of triethylamine.

R represents piperidino; cyanomethyl; or di-(carb(lower) The reaction of bis-(p-chlorophenoxy)acetic acid with alkoxy)methyl, the lower alkoxy substituent preferably a dialkylhalomalonate to form compounds of Formula containing from 1 to 4 carbon atoms, e.g., methoxy, I0 is carried out in the same manner as indicated above ethoxy, propoxy and butoxy. for the preparation of Compound lb.

The bis-(p-chlorophenoxy)acetic acid (II), employed as the starting material in the processes described above,

can be readily prepared from either the alkyl ester of his- (p-chlorophenoxy)acetic acid or dialkyl ester of bis-(p- The compound of Formula I wherein R is piperidino is prepared by converting bis-(p-chlorophenoxy)acetic acid to its corresponding acid halide and reacting the latter with l-hydroxypiperidine or an appropriate salt thereof. The compounds of Formula I wherein R is cyanochlorophecnoxwmalcfnic acid byfeacfing the same in an methyl or (Garb(lowenalkoxwmethyl are prepared by aqueous, inert organic solvent, with a strong base, at room reacting bis-(p-chlorophenoxy)acetic acid with a halot mperature or elevated temperatures. The base is preferacetonitrile or dialkylhalomalonate, respectively. These y 0116 W111ch W111 Yield a WatflFSOlHble Salt of e esired processes are illustrated by the following reaction acid, e.g., sodium hydroxide and potassium hydroxide. The scheme: acid is then obtained by simply treating the thus-obtained (ClQ-Oh-CHC OX (Cl-@Ok-CHCOOH or Alcoholate wherein R represents lower alkyl, preferably containing salt with a mineral acid, such as hydrochloric acid, in confrom 1 to 4 carbon atoms, e.g., methyl, ethyl, propyl and ventional manner. The monoand dialkyl esters referred hutyl, and X represents halo having an atomic weight of to above are prepared by reacting p-chlorosodium phenolfrom 35 to 80, i.e. chloro or brorno. ate (prepared from p-chlorophenol and sodium hydride) In the preparation of compound Ia, bis-(p-chlorophewith an alkyldichloroacetate or dialkyldibromomalonate, noxy)acetic acid (H) is converted to the corresponding respectively. The reaction is readily carried out in a suitacid halide (III) by reaction with thionyl chloride or able inert organic solvent, e.g., dimethylacetamide, diethother suitable reagent commonly used for this purpose, ylacetamide and dimethylformamide, and at room teme.g., thionyl bromide, phosphorus pentachloride and phospcrature or elevated temperatures (which should not exphorus pentabromide. The reaction is conveniently carried ceed about 80 C. when it is desired to prepare the dialkyl out in a suitable inert organic solvent and at room esters of bis-(p-chlorophenoxy)malonic acid).

temperature (20 C.) or elevated temperatures up Various of the dialkylhalomalonates employed in the to reflux temperature of the system. However, the preparation of compounds of Formula 10 are known and use of a solvent is not necessary since an excess can be prepared as described in the literature. Such others which may not be specifically disclosed in the literature may be prepared in analogous manner.

The compounds of structural Formula I are useful because they possess pharmacological activity in animals. In particular, the compounds possess marked hypocholesteremic activity and can be used as hypochloesteremic/ hypolipemic agents.

For such usage, the compounds may be admixed with conventional pharmaceutical carriers, and other adjuvants, if necessary, and administered orally in such forms as tablets, elixirs, suspensions or solutions. The dosage administered will, of course, very depending on the compound employed. However, in general satisfactory results are obtained when administered at a daily dosage of from about 4 milligrams to about 30 milligrams per kilogram of animal body weight, preferably given in divided doses, 2 to 4 times a day, or in sustained release form. For most mammals the administration of from about 0.25 gram to about 2 grams of the compound in divided doses from about 62.5 milligrams to about 1000 milligrams 2 to 4 times a day, is adequate for the treatment of hypercholesteremia/hypolipemia.

A representative formulation suitable for oral administration is a tablet (prepared by standard tabletting procedures) and containing, by weight, 50 parts of bis-(p-chlorophenoxy)acetic acid, ester with l-hydroxypiperidine, 2 parts of tragacanth, 39.5 parts of lactose, 5 parts of corn starch, 3 parts of talcum and 0.5 part of magnesium stearate.

The following examples show representative compounds contemplated by the present invention and the manner in which said compounds are prepared. However, it is to be understood that the examples are intended for the purpose of illustration only and are not intended as in any way limiting the scope of the invention which is defined in the appended claims.

EXAMPLE 1 Bis-(p-chlorophenoxy)acetic acid, ester with l-hydroxypiperidine A mixture of 20.2 g. (0.2 mole) of l-hydroxypiperidine and 800 ml. of absolute diethyl ether is stirred and cooled to about C. in an ice-salt bath. To the cooled mixture is then added dropwise with stirring a soltuion of 33.15 g. (0.1 mole) of bis-(p-chlorophenoxy)acetyl chloride in 400 ml. of absolute diethyl ether, while maintaining the temperature of the reaction mixture between to 0 C. with external cooling. After the addition is completed, the mixture is stirred for an additional 20 minutes and then, while cooling, 400 ml. of a cold saturated solution of sodium carbonate is added and the phases separated. The aqueous phase is extracted with 500 ml. of absolute diethyl ether. The combined organic phases are then washer twice with 400 ml. (each) of cold water, dried over anhydrous potassium carbonate and evaporated to dryness. The residue is recrystallized from absolute diethyl ether, using some charcoal as a decolorizing agent, to obtain bis-(pchlorophenoxy) acetic acid, ester with l-hydroxypiperidine, M.P. 89-895 C.

4 EXAMPLE 2 Bis-(p-chlorophenoxy) acetic acid cyanomethyl ester CHCO O CHzCN A mixture of 50 g. (0.16 mole) of bis-(p-chlorophenoxy)acetic acid, 24.2 g. of triethylamine and 18.1 g. (0.24 mole) of chloroacetonitrile and 240 ml. of ethyl acetate is refluxed on a steam bath for 24 hours, then filtered and the ethyl acetate solution extracted once with 500 ml. of Water and then twice with 500 ml. (each) of 2 N hydrochloric acid. The ethyl acetate layer is then dried over sodium carbonate, filtered with charcoal and then evaporated. The residue is crystallized and recrystallized from diethyl ether-petroleum ether (1:1) and washed with isopropyl ether to obtain bis-(p-chlorophenoxy)acetic acid cyanomethyl ester, M.P. -76 C.

EXAMPLE 3 Bis-(p-chlorophenoxy)acetic acid dicarbethoxymethyl ester /CHC O 0 CH C O O CzHl ClQ-O A mixture of 50 g. (0.16 mole) of bis-(p-chlorophenoxy)acetic acid, 24.2 g. (0.24 mole) of triethylamine, 57.3 g. of (0.24 mole) of diethylbromomalonate and 240 ml. of ethyl acetate is refluxed on a steam bath for 24 hours, then filtered and the ethyl acetate solution extracted once with 500 ml. of water and then twice with 500 ml. of 2 N hydrochloric acid. Then ethyl acetate layer is then dried over sodium carbonate, filtered with charcoal and then evaporated. The residue is distilled using a high vacuum difiusion pump and a maximum oil bath temperature of 250 C. to obtain bis-(p-chlorophenoxy)acetic acid dicarethoxymethyl ester, B.P. l98228 C./0.0010.002 mm.

What is claimed is: 1. A compound of the formula CHCOOR Q Cl- 0 wherein R represents piperidino, cyanomethyl or di(carb(lower) alkoxy) methyl. 2. Bis- (p-chlorophenoxy) acetic acid, ester with 1-hydroxypiperidine.

3. Bis-(p-chlorophenoxy)acetic acid cyanomethyl ester. 4. Bis-(pchlorophenoxy) acetic acid dicarbethoxymethyl ester.

References Cited UNITED STATES PATENTS 2,765,224 10/1956 Lambrech 71-107 OTHER REFERENCES Brunet et al., Bull. Soc. Chim. France. vol. 1964, No. 2, pp. 383-385.

HENRY R. JILES, Primary Examiner.

G. T. TODD, Assistant Examiner.

U.S. Cl. X.R. 

